Skip to main content

Table 3 Study results

From: Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study

Variable

Mean

SD

95% [CI]

Baseline pVO2 (ml/kg/min)

20.6

7.0

[15.89, 25.30]

12-week pVO2 (ml/kg/min)

23.2

8.5

[17.49, 28.91]

Difference

-2.6

2.5

[-4.32, 9.52]

Baseline pW (watt)

143.3

60.6

[102.58, 184.01]

12-week pW (watt)

158.6

67.5

[113.25, 203.94]

Difference

-15.4

17.0

[-41.75, 72.35]

Baseline pRER (value)

1.22

0.1

[1.15, 1.28]

12-week pRER (value)

1.22

0.1

[1.15, 1.28]

Difference

0

0.06

[-0.08, 0.08]

Baseline HRmax (beats/min)

144.6

20.0

[131.16, 158.03]

12-week HRmax(beats/min)

141.0

18.8

[128.37, 153.63]

Difference

3.6

6.0

[-13.66, 20.86]

Baseline BMI (kg/m2)

28.3

3.0

[26.28, 30.31]

12-week BMI (kg/m2)

28.3

3.2

[26.15, 30.45]

Difference

0

0.4

[-2.75, 2.75]

Baseline Fat mass (kg)

27.0

7.6

[21.89, 32.11]

12-week Fat mass (kg)

26.6

7.9

[21.29, 31.90]

Difference

0.4

1.1

[-6.49, 7.29]

Baseline Lean mass (kg)

31.5

8.8

[25.58, 37.41]

12-week Lean mass (kg)

31.7

8.4

[26.05, 37.34]

Difference

-0.2

0.5

[-7.45, 7.85]

  1. SD, standard deviation; RER, respiratory exchange ratio; HR, heart rate; ES effect size, CI confidence interval, BMI, body mass index; pVO2, peak oxygen consumption.